| Record ID | marc_records_scriblio_net/part19.dat:81247879:1350 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part19.dat:81247879:1350?format=raw |
LEADER: 01350cam 2200337 a 4500
001 87006647
003 DLC
005 19871015000000.0
008 870309s1987 stka b 10100 eng c
010 $a 87006647
020 $a0443039208 (pbk.)
020 $z0443035911
020 $z0443035946 (pbk.)
040 $aDNLM/DLC$cDLC
050 0 $aRC685.H8$bH938 1987
060 $aWG 340 H99682 1985
082 0 $a616.1/32061$219
245 00 $aHypertension--the next decade :$bverapamil in focus : proceedings of an international symposium, Berlin ICC, 10-11 October 1985 /$cedited by A.A. Fleckenstein, J.H. Laragh ; supported by Knoll AG, Ludwigshafen, FRG.
260 0 $aEdinburgh ;$aNew York :$bChurchill Livingstone,$c1987.
300 $axxvi, 381 p. :$bill. (some col.) ;$c24 cm.
504 $aIncludes bibliographies and index.
650 0 $aVerapamil$xCongresses.
650 0 $aHypertension$xChemotherapy$xCongresses.
650 0 $aHypotensive agents$xCongresses.
650 0 $aCalcium$xAntagonists$xTherapeutic use$xCongresses.
650 2 $aCalcium Channel Blockers$xtherapeutic use$xcongresses.
650 2 $aHypertension$xdrug therapy$xcongresses.
650 2 $aVerapamil$xtherapeutic use$xcongresses.
700 10 $aFleckenstein, Albrecht.
700 10 $aLaragh, John H.,$d1924-
710 20 $aKnoll AG (Ludwigshafen am Rhein, Germany)